Patent Armory v. Independent Health Association: Voluntary Dismissal After 258 Days
Patent Armory, Inc. asserted five patents covering intelligent call routing and auction-matching systems against Independent Health Association, Inc. in the Southern District of New York. The plaintiff filed a unilateral voluntary dismissal under Rule 41 before the defendant had answered, ending the case in under nine months.
Five call-routing patents dropped before Independent Health responded
Patent Armory, Inc. filed Case No. 1:25-cv-06364 in the Southern District of New York on 1 August 2025, asserting five patents — US9456086B1, US10491748B1, US7269253B1, US7023979B1, and US10237420B1 — against Independent Health Association, Inc. The asserted patents span intelligent communication routing systems, telephony control with intelligent call routing, and methods and systems for matching entities in an auction. The case was assigned to Judge Ronnie Abrams.
The recorded basis of termination is Voluntary dismissal. The docket order states that, pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(i), the plaintiff dismissed the action without prejudice, and that the defendant had not yet answered the complaint or moved for summary judgment at the time of dismissal. A Rule 41(a)(1)(A)(i) notice of dismissal filed before any responsive pleading operates as of right and requires no court order.
The case resolved in 258 days — before any substantive litigation activity by the defendant is recorded in the public docket. What drove the decision to dismiss, and whether any discussions between the parties preceded it, is not disclosed in the available record. Because the dismissal is without prejudice, Patent Armory retains the ability to refile these claims, subject to applicable procedural constraints.
See Complete Case & Patent Analysis →Filing to Voluntary dismissal in 258 days
258 days from filing to voluntary dismissal — resolved before defendant answered
US9456086B1 and four further patents — intelligent call routing and telephony control
Any organisation deploying intelligent call routing, telephony control systems, or auction-based lead matching — particularly in the health plan, managed care, or health-tech contact centre space — should treat this five-patent portfolio as an active FTO priority. The without-prejudice dismissal means Patent Armory retains full enforcement rights, and no invalidity or non-infringement finding was made in this proceeding.
Official order — verbatim text
The dismissal notice invokes Rule 41(a)(1)(A)(i) and expressly states that the defendant had not yet answered or moved for summary judgment, confirming the plaintiff's unilateral right to dismiss. The without-prejudice designation means no claim or issue was adjudicated, and neither party obtained a binding merits determination from the court.
Voluntarily dismissed: what the Rule 41 exit means for both parties
Rule 41(a)(1)(A)(i): plaintiff's unilateral right to dismiss
A notice of dismissal filed under Rule 41(a)(1)(A)(i) is self-executing — it takes effect the moment it is filed, requires no court order, and is available only before the opposing party has served an answer or a motion for summary judgment. Because Independent Health had done neither, Patent Armory exercised this right unilaterally to exit the case.
No court order requiredWithout prejudice: the claims can be refiled
The dismissal is explicitly without prejudice, meaning Patent Armory's infringement claims on all five patents are not extinguished. The public record does not specify whether the parties reached any agreement, and the specific terms — if any — are not disclosed in the available record. The without-prejudice designation preserves Patent Armory's ability to refile, subject to applicable statutes of limitations and procedural rules.
Claims survive dismissalIndependent Health exits without a merits ruling
Independent Health Association obtained a clean exit from this litigation without having to file an answer, engage in discovery, or obtain a judgment. No finding of non-infringement or invalidity was made. The absence of a merits ruling means this dismissal provides no estoppel protection against a future assertion of the same five patents by Patent Armory.
No estoppel protectionFive call-routing patents remain active enforcement tools
Because the dismissal is without prejudice and no validity or infringement determination was made, all five asserted patents retain their enforceability. Organisations operating intelligent call routing, telephony control, or auction-matching systems — particularly in the health insurance and managed care sector — should treat these patents as live enforcement assets. The specific terms of any resolution between the parties are not disclosed in the available record.
Patents remain enforceableFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Patent Armory, Inc. | Company | /Search in Eureka ↗ |
| Defendant | Independent Health Association, Inc. | Company | /Search in Eureka ↗ |
| Plaintiff counsel | Isaac Rabicoff | Attorney | Counsel for Patent Armory, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Rabicoff Law LLC | Law Firm | Representing Patent Armory, Inc.Search in Eureka ↗ |
| Presiding judge | Judge Ronnie Abrams | Judge | New York Southern District CourtSearch in Eureka ↗ |
R&D signals in intelligent call routing and telephony IP
Forward-looking patent and innovation intelligence derived from Patent Armory's five-patent call routing portfolio and Independent Health's position in the health communications technology space.
Patent Armory's call routing portfolio: scope and filing activity
Patent Armory asserted five patents spanning application numbers from US10/385389 to US15/856729, suggesting a multi-generation portfolio built across different telephony and routing technology waves. Monitoring this portfolio for continuation filings, claim amendments, and new application activity can signal where the entity intends to focus future enforcement.
Portfolio monitoringFiling trends in intelligent communication routing systems
The intelligent call routing and telephony control domain continues to see active patent filing as AI-driven routing, natural language processing, and cloud-based contact centre platforms evolve. Understanding the density of filings around the claim space covered by US9456086B1 and co-asserted patents can identify design-around opportunities and freedom-to-operate corridors for product teams.
Landscape mappingIndependent Health's IP position in health communications technology
Independent Health Association operates managed care and health plan services that rely on contact centre and member communication infrastructure. Assessing whether Independent Health holds defensive patents in call routing, member engagement systems, or communication platforms can reveal the strength of its IP posture against future assertions from this or similar patent portfolios.
Defensive IP analysisAdjacent R&D opportunity: AI-native call routing beyond existing claim scope
The asserted patents reflect telephony architectures developed across application windows predating widespread AI-native contact centre platforms. R&D teams developing large language model-driven call routing, real-time transcription-based routing, or predictive member communication systems may find white space adjacent to the existing claim boundaries of this portfolio worth mapping for novel filings.
Innovation white spaceSimilar call routing and telephony patent cases in federal district courts
Explore patent infringement cases involving intelligent call routing, telephony control, and communication matching systems litigated in the Southern District of New York and peer courts.
What this case signals for the call routing IP landscape
A pre-answer voluntary dismissal across five patents in the health-tech communications space raises questions about enforcement strategy and portfolio risk.
Pre-answer dismissals preserve maximum optionality for patent asserters
By dismissing before Independent Health answered, Patent Armory preserved its full right to refile. Companies receiving pre-answer demand letters or complaints from patent assertion entities in the call routing space should assess whether a responsive pleading — or proactive invalidity filings — could alter the asserter's cost-benefit calculus before a dismissal is elected.
Health sector operators face recurring call-routing patent exposure
The five asserted patents cover intelligent call routing and telephony control systems that are commonly deployed in health insurance contact centres. Managed care and health plan operators using commercial or proprietary call routing platforms should assess FTO exposure against US9456086B1, US10491748B1, US7269253B1, US7023979B1, and US10237420B1 before this portfolio is reasserted.
Patent v Independent — key questions answered
The case ended via voluntary dismissal. The plaintiff, Patent Armory, Inc., filed a notice of dismissal under Federal Rule of Civil Procedure 41(a)(1)(A)(i), dismissing the action without prejudice. The docket records that the defendant had not yet answered the complaint or moved for summary judgment at the time of dismissal. The recorded basis of termination is Voluntary dismissal.
Patent Armory asserted five patents: US9456086B1 (App. US12/719827), US10491748B1 (App. US15/797070), US7269253B1 (App. US11/387305), US7023979B1 (App. US10/385389), and US10237420B1 (App. US15/856729). The patents cover intelligent communication routing systems and methods, telephony control systems with intelligent call routing, and methods and systems for matching entities in an auction.
A voluntary dismissal without prejudice means the action is terminated but no merits determination was made. Independent Health Association obtained no finding of non-infringement or invalidity. Because the dismissal is without prejudice, Patent Armory retains the right to refile claims on the same five patents against the same or different defendants, subject to applicable procedural and limitations rules.
The specific terms of any resolution between the parties are not disclosed in the available public record. The dismissal was filed unilaterally by the plaintiff under Rule 41(a)(1)(A)(i) before the defendant had answered. Whether any agreement between the parties preceded the dismissal is not stated in the docket order.
The without-prejudice dismissal in this case means all five asserted patents remain enforceable, and no invalidity finding was made. Organisations operating intelligent call routing, telephony control, or auction-based communication matching systems — particularly in the health insurance and managed care sector — should consider conducting freedom-to-operate analysis against US9456086B1, US10491748B1, US7269253B1, US7023979B1, and US10237420B1.
This page is compiled from public court dockets and third-party patent and litigation data via PatSnap Eureka, and is provided for general informational purposes only. The information shown — including party names, patent and application numbers, dates, case status, outcomes, and any analysis — may be incomplete, may not reflect the most recent filings or legal status, and may contain errors or omissions. Verify all details against official court records (for example, PACER) and the relevant patent office before relying on them.
Nothing on this page constitutes legal advice or a legal opinion on the validity, infringement, enforceability, or scope of any patent or case, and no attorney‑client relationship is created by its use. Any description of an outcome (such as a dismissal, settlement, or consent judgment) is a general summary, not a legal determination. All patents, trademarks, and company or law‑firm names are the property of their respective owners. PatSnap makes no warranty as to the accuracy or completeness of this content and disclaims, to the fullest extent permitted by law, all liability for reliance on it. For advice on a specific matter, consult qualified legal counsel.
PatSnap Eureka searches patents and litigation data to answer instantly.